Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New quinolone from Bayer undergoing extensive evaluation

Sep. 20, 1996

Antiinfective drugs in development at Daiichi

Sep. 13, 1996

Antiinfective R&D at Toyama

Sep. 13, 1996

Antirhinovirus compounds from Lilly

Sep. 13, 1996

Antibacterial 2-pyridones, a novel class of DNA gyrase inhibitors

Sep. 13, 1996

Merck & Co. discloses novel antifungal agent

Sep. 13, 1996

Natural antibacterial agent reported by Korean researchers

Sep. 13, 1996

Antibacterial agents disclosed by Hokuriku

Sep. 13, 1996

Virus susceptibility gene finally cloned

Sep. 6, 1996

Thalidomide effective in chronic erythema multiforme

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 13, 2025.
Little bite from voluntary most-favored nation Rx pricing order
BioWorld
After a week of hype, the most-favored nation (MFN) drug pricing executive order (EO) U.S. President Donald Trump signed May 12 has a lot of bark but little bite,...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
China’s NMPA gives thumbs up to Remegen’s ADC targeting HER2
BioWorld
China’s National Medical Products Administration has approved Remegen Co. Ltd.’s antibody-drug conjugate (ADC), disitamab vedotin (RC-48), for treatment of...